Lyme disease: Part I. Advances and perspectives

Journal of the American Academy of Dermatology

Volumn 64, Issue 4, 2011, Pages 619-636

  Bhate, Chinmoy ^a   Schwartz, Robert A ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

acrodermatitis chronica atrophicans; Borrelia burgdorferi; erythema migrans; Ixodes scapularis; Lyme borreliosis; Lyme disease; lymphocytoma cutis; neuroborreliosis; ticks; vector borne disease

Indexed keywords

BACTERIAL ANTIGEN; COMPLEMENT; CYTOKINE; LIPOPROTEIN; MEMBRANE PROTEIN; OUTER SURFACE PROTEIN A; PROTEIN DBPA; PROTEIN OSPC; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ARTHROPATHY; BABESIOSIS; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM CARRIER; BORRELIA; BORRELIA AFZELII; BORRELIA BISSETTI; BORRELIA BURGDORFERI; BORRELIA GARINII; BORRELIA LUSITANIAE; BORRELIA SPIELMANII; CELL STIMULATION; CLINICAL FEATURE; COMPLEMENT ACTIVATION; DISEASE COURSE; DOWN REGULATION; EHRLICHIOSIS; ENDEMIC DISEASE; ERYTHEMA CHRONICUM MIGRANS; GEOGRAPHIC DISTRIBUTION; HEART DISEASE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; INNATE IMMUNITY; IXODES; LYME DISEASE; MIXED INFECTION; NEUROLOGIC DISEASE; NONHUMAN; NYMPH; PATHOGENESIS; PHAGOCYTE; PREGNANCY; PREVALENCE; PRIORITY JOURNAL; RASH; REVIEW; RHEUMATIC DISEASE; SKIN MANIFESTATION; SPIROCHETE INFECTION; SYPHILIS;

ANIMALS; BORRELIA BURGDORFERI; EDUCATION, MEDICAL, CONTINUING; HUMANS; IXODES; LYME DISEASE;

EID: 79952795173     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2010.03.046     Document Type: Review

References (264)

1. Bacon RM, Kugeler KJ, Mead PS. Surveillance for Lyme disease - United States, 1992-2006. MMWR Surveill Summ 2008;57:1-9.
2. Dennis DT, Nekomoto TS, Victor JC, Paul WS, Piesman J. Reported distribution of Ixodes scapularis and Ixodes pacificus (Acari: Ixodidae) in the United States. J Med Entomol 1998;35:629-38. (Pubitemid 128463421)
3. Weber K. Aspects of Lyme borreliosis in Europe. Eur J Clin Microbiol Infect Dis 2001;20:6-13. (Pubitemid 32200355)
4. Gray J. Risk assessment in Lyme borreliosis. Wien Klin Wochenschr 1999;111:990-3. (Pubitemid 30026422)
5. Dressler F. Lyme borreliosis in European children and adolescents. Clin Exp Rheumatol 1994;12(suppl 10):S49-54.
6. Masuzawa T. Terrestrial distribution of the Lyme borreliosis agent Borrelia burgdorferi sensu lato in East Asia. Jpn J Infect Dis 2004;57:229-35. (Pubitemid 40260237)
7. Hercogová J, Brzonova I. Lyme disease in central Europe. Curr Opin Infect Dis 2001;14:133-7. (Pubitemid 32231098)
8. Stanek G, Fingerle V, Hunfeld KP, Jaulhac B, Kaiser R, Krause A, et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect 2011;17:69-79.
9. Hercogová J, Vanousová D. Syphilis and borreliosis during pregnancy. Dermatol Ther 2008;21:205-9.
10. Steere AC. Lyme disease. N Engl J Med 2001;345:115-25. (Pubitemid 32640193)
11. Gerber MA, Shapiro ED, Burke GS, Parcells VJ, Bell GL. Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group. N Engl J Med 1996;335:1270-4. (Pubitemid 26349268)
12. Schutzer SE, Schwartz RA. Diagnosing Lyme disease: often simple, often difficult. Cutis 1991;47:229-30, 32.
13. Steere AC, Sikand VK. The presenting manifestations of Lyme disease and the outcomes of treatment. N Engl J Med 2003;348:2472-4. (Pubitemid 36682836)
14. Müllegger RR. Dermatological manifestations of Lyme borreliosis. Eur J Dermatol 2004;14:296-309. (Pubitemid 39222329)
15. Steen CJ, Carbonaro PA, Schwartz RA. Arthropods in dermatology. J Am Acad Dermatol 2004;50:819-42.
16. Smith RP, Schoen RT, Rahn DW, Sikand VK, Nowakowski J, Parenti DL, et al. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans. Ann Intern Med 2002;136:421-8. (Pubitemid 34233173)
17. Buchwald A. Ein Fall von diffuser idiopathischer Haut-Atrophie. Arch Dermatol Syphilol 1883;10:553-6.
18. Weber K. History of Lyme borreliosis in Europe. In: Weber K, Burgdorfer W, editors. Aspects of Lyme borreliosis. Berlin: Springer-Verlag; 1993. pp. 1-20.
19. Herxheimer K, Hartmann K. Ueber Acrodermatitis chronica atrophicans. Arch f Dermatol u Syph (Wien) 1902;61:57-76.
20. Afzelius A. Erythema chronicum migrans. Acta Derm Venereol 1921;2:120-5.
21. Steere AC. Lyme borreliosis in 2005, 30 years after initial observations in Lyme, Connecticut. Wien Klin Wochenschr 2006;118:625-33.
22. Lipschütz B. Uber eine seltene Erythemform (erythema chronicum migrans). Arch Dermatol Syph 1913;118:349-56.
23. Hellerstrom S. Erythema chronicum migrans Afzelii. Acta Derm Venereol (Stockh) 1930;11:315-21.
24. Lenhoff C. Spirochetes in aetiologically obscure diseases. Acta Derm Venereol 1948;28:295-324.
25. Thyresson N. The penicillin treatment of acrodermatitis atrophicans chronica (Herxheimer). Acta Derm Venereol 1949;29:572-621.
26. Steere AC. Lyme disease. N Engl J Med 1989;321:586-96. (Pubitemid 19212871)
27. Steere AC, Malawista SE, Snydman DR, Shope RE, Andiman WA, Ross MR, et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 1977;20:7-17.
28. Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP. Lyme disease - a tick-borne spirochetosis? Science 1982;216:1317-9.
29. Burgdorfer W. Arthropod-borne spirochetoses: a historical perspective. Eur J Clin Microbiol Infect Dis 2001;20:1-5. (Pubitemid 32200354)
30. Fraser CM, Casjens S, Huang WM, Sutton GG, Clayton R, Lathigra R, et al. Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 1997;390:580-6. (Pubitemid 28016185)
31. Hashimoto S, Kawado M, Murakami Y, Izumida M, Ohta A, Tada Y, et al. Epidemics of vector-borne diseases observed in infectious disease surveillance in Japan, 2000-2005. J Epidemiol 2007;17(suppl):S48-55.
32. Fulop B, Poggensee G. Epidemiological situation of Lyme borreliosis in Germany: surveillance data from six Eastern German States, 2002 to 2006. Parasitol Res 2008;103(suppl 1):117-20.
33. Lyme disease - United States, 2000. MMWR Morb Mortal Wkly Rep 2002;51:29-31.
34. Chow CC, Evans AS Jr, Noonan-Toly CM, White D, Johnson GS, Marks SJ, et al. Lyme disease trends - Dutchess County, New York, 1992-2000. Mt Sinai J Med 2003;70:207-13.
35. Kudish K, Sleavin W, Hathcock L. Lyme disease trends: Delaware, 2000-2004. Del Med J 2007;79:51-8.
36. Pena CA, Strickland GT. Incidence rates of Lyme disease in Maryland: 1993 through 1996. Md Med J 1999;48:68-73.
37. Huppertz HI, Bohme M, Standaert SM, Karch H, Plotkin SA. Incidence of Lyme borreliosis in the Wurzburg region of Germany. Eur J Clin Microbiol Infect Dis 1999;18:697-703. (Pubitemid 29537447)
38. Clover JR, Lane RS. Evidence implicating nymphal Ixodes pacificus (Acari: ixodidae) in the epidemiology of Lyme disease in California. Am J Trop Med Hyg 1995;53:237-40.
39. Doggett JS, Kohlhepp S, Gresbrink R, Metz P, Gleaves C, Gilbert D. Lyme disease in Oregon. J Clin Microbiol 2008;46:2115-8. (Pubitemid 351831858)
40. Rauter C, Hartung T. Prevalence of Borrelia burgdorferi sensu lato genospecies in Ixodes ricinus ticks in Europe: a metaanalysis. Appl Environ Microbiol 2005;71:7203-16. (Pubitemid 43194214)
41. Stanek G, Satz N, Strle F, Wilske B. Epidemiology of Lyme borreliosis. In: Weber K, Burgdorfer W, editors. Aspects of Lyme borreliosis. Berlin: Springer-Verlag; 1993. pp. 358-70.
42. Berglund J, Eitrem R, Ornstein K, Lindberg A, Ringer A, Elmrud H, et al. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 1995;333:1319-27.
43. Kondrat'ev VG, Bykova LA, Poltoratskaia TN, Istratkina SV. The epidemic situation of tick-borne encephalitis and Lyme disease in the city of Tomsk [in Russian]. Med Parazitol (Mosk) 1998;1:52-3.
44. Beklemishev AB, Dobrotvorsky AK, Piterina AV, Ivanov ID, Nomokonova NY, Livanova NN. Detection and typing of Borrelia burgdorferi sensu lato genospecies in Ixodes persulcatus ticks in West Siberia, Russia. FEMS Microbiol Lett 2003;227:157-61. (Pubitemid 37329871)
45. Lindgren E, Talleklint L, Polfeldt T. Impact of climatic change on the northern latitude limit and population density of the disease-transmitting European tick Ixodes ricinus. Environ Health Perspect 2000;108:119-23. (Pubitemid 30153916)
46. Brownstein JS, Holford TR, Fish D. Effect of climate change on Lyme disease risk in North America. Ecohealth 2005;2:38-46. (Pubitemid 40568873)
47. Ogden NH, St-Onge L, Barker IK, Brazeau S, Bigras-Poulin M, Charron DF, et al. Risk maps for range expansion of the Lyme disease vector, Ixodes scapularis, in Canada now and with climate change. Int J Health Geogr 2008;7:24.
48. Ogden NH, Lindsay LR, Morshed M, Sockett PN, Artsob H. The emergence of Lyme disease in Canada. CMAJ 2009;180:1221-4.
49. Barbour AG, Hayes SF. Biology of Borrelia species. Microbiol Rev 1986;50:381-400. (Pubitemid 17202895)
50. Dombrowski C, Kan W, Motaleb MA, Charon NW, Goldstein RE, Wolgemuth CW. The elastic basis for the shape of Borrelia burgdorferi. Biophys J 2009;96:4409-17.
51. Haake DA. Spirochaetal lipoproteins and pathogenesis. Microbiology 2000;146(pt 7):1491-504. (Pubitemid 30458704)
52. Guo BP, Brown EL, Dorward DW, Rosenberg LC, Hook M. Decorin-binding adhesins from Borrelia burgdorferi. Mol Microbiol 1998;30:711-23. (Pubitemid 28528591)
53. Indest KJ, Howell JK, Jacobs MB, Scholl-Meeker D, Norris SJ, Philipp MT. Analysis of Borrelia burgdorferi vlsE gene expression and recombination in the tick vector. Infect Immun 2001;69:7083-90. (Pubitemid 32995469)
54. Xu Q, McShan K, Liang FT. Essential protective role attributed to the surface lipoproteins of Borrelia burgdorferi against innate defences. Mol Microbiol 2008;69:15-29. (Pubitemid 351832757)
55. Probert WS, Johnson BJ. Identification of a 47 kDa fibronectin-binding protein expressed by Borrelia burgdorferi isolate B31. Mol Microbiol 1998;30:1003-15. (Pubitemid 28550124)
56. McGinley-Smith DE, Tsao SS. Dermatoses from ticks. J Am Acad Dermatol 2003;49:363-92. (Pubitemid 37051898)
57. Fibeger EA, Erickson QL, Weintraub BD, Elston DM. Larval tick infestation: a case report and review of tick-borne disease. Cutis 2008;82:38-46.
58. Elston DM. Tick bites and skin rashes. Curr Opin Infect Dis 2010;23:132-8.
59. Rozendaal JA. Vector control: methods for use by individuals and communities. Geneva: World Health Organization; 1997.
60. Wang G, van Dam AP, Schwartz I, Dankert J. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev 1999;12:633-53. (Pubitemid 29484751)
61. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of lyme borreliosis. Clin Microbiol Rev 2005;18:484-509. (Pubitemid 40995113)
62. Ruzic-Sabljic E, Zore A, Strle F. Characterization of Borrelia burgdorferi sensu lato isolates by pulsed-field gel electrophoresis after MluI restriction of genomic DNA. Res Microbiol 2008;159:441-8.
63. Wilske B, Fingerle V, Schulte-Spechtel U. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol 2007;49:13-21. (Pubitemid 46160581)
64. Chu CY, Jiang BG, Liu W, Zhao QM, Wu XM, Zhang PH, et al. Presence of pathogenic Borrelia burgdorferi sensu lato in ticks and rodents in Zhejiang, southeast China. J Med Microbiol 2008;57:980-5.
65. Saito K, Ito T, Asashima N, Ohno M, Nagai R, Fujita H, et al. Case report: Borrelia valaisiana infection in a Japanese man associated with traveling to foreign countries. Am J Trop Med Hyg 2007;77:1124-7. (Pubitemid 351837805)
66. Strle F. Lyme borreliosis in Slovenia. Zentralbl Bakteriol 1999;289:643-52. (Pubitemid 30047261)
67. Strle F, Picken RN, Cheng Y, Cimperman J, Maraspin V, Lotric-Furlan S, et al. Clinical findings for patients with Lyme borreliosis caused by Borrelia burgdorferi sensu lato with genotypic and phenotypic similarities to strain 25015. Clin Infect Dis 1997;25:273-80. (Pubitemid 27364725)
68. Rudenko N, Golovchenko M, Mokracek A, Piskunova N, Ruzek D, Mallatova N, et al. Detection of Borrelia bissettii in cardiac valve tissue of a patient with endocarditis and aortic valve stenosis in the Czech Republic. J Clin Microbiol 2008;46:3540-3.
69. Clark K, Hendricks A, Burge D. Molecular identification and analysis of Borrelia burgdorferi sensu lato in lizards in the southeastern United States. Appl Environ Microbiol 2005;71:2616-25. (Pubitemid 40647008)
70. Richter D, Schlee DB, Allgower R, Matuschka FR. Relationships of a novel Lyme disease spirochete, Borrelia spielmani sp. nov., with its hosts in Central Europe. Appl Environ Microbiol 2004;70:6414-9. (Pubitemid 39518545)
71. Marconi RT, Liveris D, Schwartz I. Identification of novel insertion elements, restriction fragment length polymorphism patterns, and discontinuous 23S rRNA in Lyme disease spirochetes: phylogenetic analyses of rRNA genes and their intergenic spacers in Borrelia japonica sp. nov. and genomic group 21038 (Borrelia andersonii sp. nov.) isolates. J Clin Microbiol 1995;33:2427-34.
72. Postic D, Garnier M, Baranton G. Multilocus sequence analysis of atypical Borrelia burgdorferi sensu lato isolates - description of Borrelia californiensis sp. nov., and genomospecies 1 and 2. Int J Med Microbiol 2007;297:263-71. (Pubitemid 46830039)
73. Kawabata H, Masuzawa T, Yanagihara Y. Genomic analysis of Borrelia japonica sp. nov. isolated from Ixodes ovatus in Japan. Microbiol Immunol 1993;37:843-8. (Pubitemid 24021439)
74. Masuzawa T, Suzuki H, Kawabata H, Ishiguro F, Takada N, Yano Y, et al. Identification of spirochetes isolated from wild rodents in Japan as Borrelia japonica. J Clin Microbiol 1995;33:1392-4.
75. Fukunaga M, Hamase A, Okada K, Nakao M. Borrelia tanukii sp. nov. and Borrelia turdae sp. nov. found from ixodid ticks in Japan: rapid species identification by 16S rRNA gene-targeted PCR analysis. Microbiol Immunol 1996;40:877-81. (Pubitemid 27034139)
76. Masuzawa T, Takada N, Kudeken M, Fukui T, Yano Y, Ishiguro F, et al. Borrelia sinica sp. nov., a lyme disease-related Borrelia species isolated in China. Int J Syst Evol Microbiol 2001;51:1817-24. (Pubitemid 32899219)
77. Collares-Pereira M, Couceiro S, Franca I, Kurtenbach K, Schafer SM, Vitorino L, et al. First isolation of Borrelia lusitaniae from a human patient. J Clin Microbiol 2004;42:1316-8. (Pubitemid 38332878)
78. Diza E, Papa A, Vezyri E, Tsounis S, Milonas I, Antoniadis A. Borrelia valaisiana in cerebrospinal fluid. Emerg Infect Dis 2004;10:1692-3.
79. Maraspin V, Ruzic-Sabljic E, Strle F. Lyme borreliosis and Borrelia spielmanii. Emerg Infect Dis 2006;12:1177.
80. Takada N, Masuzawa T, Ishiguro F, Fujita H, Kudeken M, Mitani H, et al. Lyme disease Borrelia spp. in ticks and rodents from northwestern China. Appl Environ Microbiol 2001;67:5161-5. (Pubitemid 33701284)
81. Masuzawa T, Wilske B, Komikado T, Suzuki H, Kawabata H, Sato N, et al. Comparison of OspA serotypes for Borrelia burgdorferi sensu lato from Japan, Europe and North America. Microbiol Immunol 1996;40:539-45. (Pubitemid 26282106)
82. Franz JK, Krause A. Lyme disease (Lyme borreliosis). Best Pract Res Clin Rheumatol 2003;17:241-64.
83. Burgdorfer W. Lyme borreliosis of ticks and spirochetes. Acta Derm Venereol 1996;5:87-92.
84. Anderson JF. Epizootiology of Lyme borreliosis. Scand J Infect Dis Suppl 1991;77:23-34.
85. Killilea ME, Swei A, Lane RS, Briggs CJ, Ostfeld RS. Spatial dynamics of lyme disease: a review. Ecohealth 2008;5:167-95.
86. Gern L. Life cycle of Borrelia burgdorferi sensu lato and transmission to humans. Curr Probl Dermatol 2009;37:18-30.
87. Anderson JF, Magnarelli LA, LeFebvre RB, Andreadis TG, McAninch JB, Perng GC, et al. Antigenically variable Borrelia burgdorferi isolated from cottontail rabbits and Ixodes dentatus in rural and urban areas. J Clin Microbiol 1989;27:13-20. (Pubitemid 19021935)
88. Brown RN, Lane RS. Lyme disease in California: a novel enzootic transmission cycle of Borrelia burgdorferi. Science 1992;256:1439-42.
89. Lin T, Oliver JH Jr, Gao L, Kollars TM Jr, Clark KL. Genetic heterogeneity of Borrelia burgdorferi sensu lato in the southern United States based on restriction fragment length polymorphism and sequence analysis. J Clin Microbiol 2001;39:2500-7. (Pubitemid 32606225)
90. Schutzer SE, Brown T Jr, Holland BK. Reduction of Lyme disease exposure by recognition and avoidance of high-risk areas. Lancet 1997;349:1668. (Pubitemid 27234812)
91. Schutzer SE, Holland BK, Brown T Jr. Avoidance of tick-borne diseases. Ann Intern Med 1998;128:784.
92. Magnarelli LA, Oliver JH Jr, Hutcheson HJ, Anderson JF. Antibodies to Borrelia burgdorferi in deer and raccoons. J Wildl Dis 1991;27:562-8.
93. Stafford KC III, Denicola AJ, Kilpatrick HJ. Reduced abundance of Ixodes scapularis (Acari: Ixodidae) and the tick parasitoid Ixodiphagus hookeri (Hymenoptera: Encyrtidae) with reduction of white-tailed deer. J Med Entomol 2003;40:642-52. (Pubitemid 37399536)
94. Rand PW, Lubelczyk C, Holman MS, Lacombe EH, Smith RP Jr. Abundance of Ixodes scapularis (Acari: Ixodidae) after the complete removal of deer from an isolated offshore island, endemic for Lyme disease. J Med Entomol 2004;41:779-84. (Pubitemid 38991518)
95. Ostfeld RS, Canham CD, Oggenfuss K, Winchcombe RJ, Keesing F. Climate, deer, rodents, and acorns as determinants of variation in lyme-disease risk. PLoS Biol 2006;4:e145.
96. Eisen L, Eisen RJ, Lane RS. The roles of birds, lizards, and rodents as hosts for the western black-legged tick Ixodes pacificus. J Vector Ecol 2004;29:295-308. (Pubitemid 40335161)
97. Lane RS, Quistad GB. Borreliacidal factor in the blood of the western fence lizard (Sceloporus occidentalis). J Parasitol 1998;84:29-34. (Pubitemid 28125427)
98. Lane RS, Mun J, Eisen L, Eisen RJ. Refractoriness of the western fence lizard (Sceloporus occidentalis) to the Lyme disease group spirochete Borrelia bissettii. J Parasitol 2006;92:691-6. (Pubitemid 44435583)
99. Humair P, Gern L. The wild hidden face of Lyme borreliosis in Europe. Microbes Infect 2000;2:915-22. (Pubitemid 30483187)
100. Sinski E, Gill J, Rijpkema S. Prevalence of antibodies to Borrelia burgdorferi in European bison (bison bonasus) from Bialowieza Primeval Forest. Rocz Akad Med Bialymst 1996;41:111-6.
101. Khanakah G, Kocianová E, Výrosteková V, Rehacek J, Kundi M, Stanek G. Seasonal variations in detecting Borrelia burgdorferi sensu lato in rodents from north eastern Austria. Wien Klin Wochenschr 2006;118:754-8. (Pubitemid 46165846)
102. Kurtenbach K, Peacey M, Rijpkema SG, Hoodless AN, Nuttall PA, Randolph SE. Differential transmission of the genospecies of Borrelia burgdorferi sensu lato by game birds and small rodents in England. Appl Environ Microbiol 1998;64:1169-74. (Pubitemid 28188367)
103. Humair PF, Postic D, Wallich R, Gern L. An avian reservoir (Turdus merula) of the Lyme borreliosis spirochetes. Zentralbl Bakteriol 1998;287:521-38. (Pubitemid 28271154)
104. Yang XF, Pal U, Alani SM, Fikrig E, Norgard MV. Essential role for OspA/B in the life cycle of the Lyme disease spirochete. J Exp Med 2004;199:641-8. (Pubitemid 38316431)
105. Battisti JM, Bono JL, Rosa PA, Schrumpf ME, Schwan TG, Policastro PF. Outer surface protein A protects Lyme disease spirochetes from acquired host immunity in the tick vector. Infect Immun 2008;76:5228-37.
106. Pal U, Li X, Wang T, Montgomery RR, Ramamoorthi N, Desilva AM, et al. TROSPA, an Ixodes scapularis receptor for Borrelia burgdorferi. Cell 2004;119:457-68. (Pubitemid 39482346)
107. Matuschka FR, Schinkel TW, Klug B, Spielman A, Richter D. Failure of Ixodes ticks to inherit Borrelia afzelii infection. Appl Environ Microbiol 1998;64:3089-91. (Pubitemid 28363191)
108. Nefedova VV, Korenberg EI, Gorelova NB, Kovalevskii. YV. Studies on the transovarial transmission of Borrelia burgdorferi sensu lato in the taiga tick Ixodes persulcatus. Folia Parasitol (Praha) 2004;51:67-71. (Pubitemid 38448294)
109. Patrican LA. Absence of Lyme disease spirochetes in larval progeny of naturally infected Ixodes scapularis (Acari:Ixodidae) fed on dogs. J Med Entomol 1997;34:52-5. (Pubitemid 127460902)
110. Revel AT, Talaat AM, Norgard MV. DNA microarray analysis of differential gene expression in Borrelia burgdorferi, the Lyme disease spirochete. Proc Natl Acad Sci U S A 2002;99:1562-7. (Pubitemid 34136532)
111. Schwan TG, Piesman J, Golde WT, Dolan MC, Rosa PA. Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci U S A 1995;92:2909-13.
112. Carroll JA, Garon CF, Schwan TG. Effects of environmental pH on membrane proteins in Borrelia burgdorferi. Infect Immun 1999;67:3181-7. (Pubitemid 29291478)
113. Ewing C, Scorpio A, Nelson DR, Mather TN. Isolation of Borrelia burgdorferi from saliva of the tick vector, Ixodes scapularis. J Clin Microbiol 1994;32:755-8. (Pubitemid 24062956)
114. Tilly K, Rosa PA, Stewart PE. Biology of infection with Borrelia burgdorferi. Infect Dis Clin North Am 2008;22:217-34. (Pubitemid 351608547)
115. de Silva AM, Telford SR III, Brunet LR, Barthold SW, Fikrig E. Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. J Exp Med 1996;183:271-5. (Pubitemid 26028766)
116. Pal U, Yang X, Chen M, Bockenstedt LK, Anderson JF, Flavell RA, et al. OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J Clin Invest 2004;113:220-30. (Pubitemid 38544207)
117. Grimm D, Tilly K, Byram R, Stewart PE, Krum JG, Bueschel DM, et al. Outer-surface protein C of the Lyme disease spirochete: a protein induced in ticks for infection of mammals. Proc Natl Acad Sci U S A 2004;101:3142-7. (Pubitemid 38327748)
118. Liang FT, Yan J, Mbow ML, Sviat SL, Gilmore RD, Mamula M, et al. Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect Immun 2004;72:5759-67. (Pubitemid 39303686)
119. Leuba-Garcia S, Kramer MD, Wallich R, Gern L. Characterization of Borrelia burgdorferi isolated from different organs of Ixodes ricinus ticks collected in nature. Zentralbl Bakteriol 1994;280:468-75. (Pubitemid 2068444)
120. Miyamoto K, Hashimoto Y. Prevention of Lyme borreliosis infection after tick bites [in Chinese]. Kansenshogaku Zasshi 1998;72:512-6.
121. Piesman J, Dolan MC. Protection against lyme disease spirochete transmission provided by prompt removal of nymphal Ixodes scapularis (Acari: Ixodidae). J Med Entomol 2002;39:509-12. (Pubitemid 135700286)
122. Costello CM, Steere AC, Pinkerton RE, Feder HM Jr. A prospective study of tick bites in an endemic area for Lyme disease. J Infect Dis 1989;159:136-9. (Pubitemid 19022011)
123. Sood SK, Salzman MB, Johnson BJ, Happ CM, Feig K, Carmody L, et al. Duration of tick attachment as a predictor of the risk of Lyme disease in an area in which Lyme disease is endemic. J Infect Dis 1997;175:996-9. (Pubitemid 27142986)
124. Nahimana I, Gern L, Blanc DS, Praz G, Francioli P, Peter O. Risk of Borrelia burgdorferi infection in western Switzerland following a tick bite. Eur J Clin Microbiol Infect Dis 2004;23:603-8. (Pubitemid 39222633)
125. Hojgaard A, Eisen RJ, Piesman J. Transmission dynamics of Borrelia burgdorferi s.s. during the key third day of feeding by nymphal Ixodes scapularis (Acari: Ixodidae). J Med Entomol 2008;45:732-6.
126. Húgli D, Moret J, Rais O, Moosmann Y, Erard P, Malinverni R, et al. Tick bites in a Lyme borreliosis highly endemic area in Switzerland. Int J Med Microbiol 2009;299:155-60.
127. Hovius JW, van Dam AP, Fikrig E. Tick-host-pathogen interactions in Lyme borreliosis. Trends Parasitol 2007;23:434-8. (Pubitemid 47271975)
128. Kahl O, Janetzki-Mittmann C, Gray JS, Jonas R, Stein J, de Boer R. Risk of infection with Borrelia burgdorferi sensu lato for a host in relation to the duration of nymphal Ixodes ricinus feeding and the method of tick removal. Zentralbl Bakteriol 1998;287:41-52. (Pubitemid 28139615)
129. Lane RS, Manweiler SA, Stubbs HA, Lennette ET, Madigan JE, Lavoie PE. Risk factors for Lyme disease in a small rural community in northern California. Am J Epidemiol 1992;136:1358-68. (Pubitemid 23046420)
130. Vazquez M, Muehlenbein C, Cartter M, Hayes EB, Ertel S, Shapiro ED. Effectiveness of personal protective measures to prevent Lyme disease. Emerg Infect Dis 2008;14:210-6.
131. Ogden NH, Bigras-Poulin M, Hanincova K, Maarouf A, O'Callaghan CJ, Kurtenbach K. Projected effects of climate change on tick phenology and fitness of pathogens transmitted by the North American tick Ixodes scapularis. J Theor Biol 2008;254:621-32.
132. Cadenas FM, Rais O, Jouda F, Douet V, Humair PF, Moret J, et al. Phenology of Ixodes ricinus and infection with Borrelia burgdorferi sensu lato along a north- and south-facing altitudinal gradient on Chaumont Mountain, Switzerland. J Med Entomol 2007;44:683-93. (Pubitemid 47083504)
133. Morán Cadenas F, Rais O, Humair PF, Douet V, Moret J, Gern L. Identification of host bloodmeal source and Borrelia burgdorferi sensu lato in field-collected Ixodes ricinus ticks in Chaumont (Switzerland). J Med Entomol 2007;44:1109-17. (Pubitemid 350208246)
134. Hubálek Z, Stunzner D, Halouzka J, Sixl W, Wendelin I, Juricová Z, et al. Prevalence of borreliae in ixodid ticks from a floodplain forest ecosystem. Wien Klin Wochenschr 2003;115:121-4. (Pubitemid 36285818)
135. Gustafson R, Gardulf A, Svenungsson B. Comparison of culture, indirect immunofluorescence and dark-field microscopy for detection of spirochetes from Ixodes ricinus ticks. Eur J Clin Microbiol Infect Dis 1989;8:570-2.
136. Miserez V, Gern L, Aeschlimann A. Borrelia burgdorferi in ticks of the Canton Tessin (Switzerland). Parassitologia 1990;32:293-9.
137. Christova I, Schouls L, van De Pol I, Park J, Panayotov S, Lefterova V, et al. High prevalence of granulocytic Ehrlichiae and Borrelia burgdorferi sensu lato in Ixodes ricinus ticks from Bulgaria. J Clin Microbiol 2001;39:4172-4. (Pubitemid 33029804)
138. Fingerle V, Munderloh UG, Liegl G, Wilske B. Coexistence of ehrlichiae of the phagocytophila group with Borrelia burgdorferi in Ixodes ricinus from Southern Germany. Med Microbiol Immunol 1999;188:145-9. (Pubitemid 30085361)
139. Golubic D, Rijpkema S, Tkalec-Makovec N, Ruzic E. Epidemiologic, ecologic and clinical characteristics of Lyme borrelliosis in northwest Croatia. Acta Med Croatica 1998;52:7-13.
140. Varde S, Beckley J, Schwartz I. Prevalence of tick-borne pathogens in Ixodes scapularis in a rural New Jersey County. Emerg Infect Dis 1998;4:97-9. (Pubitemid 28347421)
141. Dolan MC, Maupin GO, Schneider BS, Denatale C, Hamon N, Cole C, et al. Control of immature Ixodes scapularis (Acari: Ixodidae) on rodent reservoirs of Borrelia burgdorferi in a residential community of southeastern Connecticut. J Med Entomol 2004;41:1043-54. (Pubitemid 39606427)
142. Morshed MG, Scott JD, Fernando K, Geddes G, McNabb A, Mak S, et al. Distribution and characterization of Borrelia burgdorferi isolates from Ixodes scapularis and presence in mammalian hosts in Ontario, Canada. J Med Entomol 2006;43:762-73. (Pubitemid 44734929)
143. Scott JD, Lee MK, Fernando K, Jorgensen DR, Durden LA, Morshed MG. Rapid introduction of Lyme disease spirochete, Borrelia burgdorferi sensu stricto, in Ixodes scapularis (Acari: Ixodidae) established at Turkey Point Provincial Park, Ontario, Canada. J Vector Ecol 2008;33:64-9.
144. des Vignes F, Piesman J, Heffernan R, Schulze TL, Stafford KC III, Fish D. Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphs. J Infect Dis 2001;183:773-8.
145. Falco RC, Fish D, Piesman J. Duration of tick bites in a Lyme disease-endemic area. Am J Epidemiol 1996;143:187-92. (Pubitemid 26036260)
146. Hirschfeld M, Kirschning CJ, Schwandner R, Wesche H, Weis JH, Wooten RM, et al. Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol 1999;163:2382-6. (Pubitemid 29399155)
147. Wooten RM, Ma Y, Yoder RA, Brown JP, Weis JH, Zachary JF, et al. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J Immunol 2002;168:348-55. (Pubitemid 34014136)
148. Liu N, Montgomery RR, Barthold SW, Bockenstedt LK. Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferieinfected mice. Infect Immun 2004;72:3195-203. (Pubitemid 38697740)
149. Berende A, Oosting M, Kullberg BJ, Netea MG, Joosten LA. Activation of innate host defense mechanisms by Borrelia. Eur Cytokine Netw 2010;21:7-18.
150. Morrison TB, Weis JH, Weis JJ. Borrelia burgdorferi outer surface protein A (OspA) activates and primes human neutrophils. J Immunol 1997;158:4838-45. (Pubitemid 127483805)
151. Hartiala P, Hytonen J, Suhonen J, Lepparanta O, Tuominen-Gustafsson H, Viljanen MK. Borrelia burgdorferi inhibits human neutrophil functions. Microbes Infect 2008;10:60-8.
152. Esteve-Gassent MD, Elliott NL, Seshu J. sodA is essential for virulence of Borrelia burgdorferi in the murine model of Lyme disease. Mol Microbiol 2009;71:594-612.
153. Montgomery RR, Lusitani D, De Boisfleury Chevance A, Malawista SE. Tick saliva reduces adherence and area of human neutrophils. Infect Immun 2004;72:2989-94. (Pubitemid 38542429)
154. Guo X, Booth CJ, Paley MA, Wang X, DePonte K, Fikrig E, et al. Inhibition of neutrophil function by two tick salivary proteins. Infect Immun 2009;77:2320-9.
155. Kurtenbach K, Sewell HS, Ogden NH, Randolph SE, Nuttall PA. Serum complement sensitivity as a key factor in Lyme disease ecology. Infect Immun 1998;66:1248-51. (Pubitemid 28101172)
156. Stevenson B, Tilly K, Rosa PA. A family of genes located on four separate 32-kilobase circular plasmids in Borrelia burgdorferi B31. J Bacteriol 1996;178:3508-16. (Pubitemid 26179055)
157. Stevenson B, Bono JL, Schwan TG, Rosa P. Borrelia burgdorferi erp proteins are immunogenic in mammals infected by tick bite, and their synthesis is inducible in cultured bacteria. Infect Immun 1998;66:2648-54. (Pubitemid 28261765)
158. Kraiczy P, Skerka C, Kirschfink M, Zipfel PF, Brade V. Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates. Int Immunopharmacol 2001;1:393-401. (Pubitemid 32197538)
159. Kraiczy P, Skerka C, Kirschfink M, Brade V, Zipfel PF. Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H. Eur J Immunol 2001;31:1674-84. (Pubitemid 32547329)
160. Hellwage J, Meri T, Heikkilä T, Alitalo A, Panelius J, Lahdenne P, et al. The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem 2001;276:8427-35.
161. van Dam AP, Oei A, Jaspars R, Fijen C, Wilske B, Spanjaard L, et al. Complement-mediated serum sensitivity among spirochetes that cause Lyme disease. Infect Immun 1997;65:1228-36. (Pubitemid 27146607)
162. Stewart PE, Wang X, Bueschel DM, Clifton DR, Grimm D, Tilly K, et al. Delineating the requirement for the Borrelia burgdorferi virulence factor OspC in the mammalian host. Infect Immun 2006;74:3547-53. (Pubitemid 43794546)
163. Schuijt TJ, Hovius JW, van Burgel ND, Ramamoorthi N, Fikrig E, van Dam AP. The tick salivary protein Salp15 inhibits the killing of serum-sensitive Borrelia burgdorferi sensu lato isolates. Infect Immun 2008;76:2888-94.
164. Ramamoorthi N, Narasimhan S, Pal U, Bao F, Yang XF, Fish D, et al. The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature 2005;436:573-7. (Pubitemid 41112932)
165. Anguita J, Ramamoorthi N, Hovius JW, Das S, Thomas V, Persinski R, et al. Salp15, an ixodes scapularis salivary protein, inhibits CD4(1) T cell activation. Immunity 2002;16:849-59.
166. Seshu J, Esteve-Gassent MD, Labandeira-Rey M, Kim JH, Trzeciakowski JP, Hook M, et al. Inactivation of the fibronectin-binding adhesin gene bbk32 significantly attenuates the infectivity potential of Borrelia burgdorferi. Mol Microbiol 2006;59:1591-601.
167. Li X, Liu X, Beck DS, Kantor FS, Fikrig E. Borrelia burgdorferi lacking BBK32, a fibronectin-binding protein, retains full pathogenicity. Infect Immun 2006;74:3305-13. (Pubitemid 43794518)
168. Krause A, Burmester GR, Rensing A, Schoerner C, Schaible UE, Simon MM, et al. Cellular immune reactivity to recombinant OspA and flagellin from Borrelia burgdorferi in patients with Lyme borreliosis. Complexity of humoral and cellular immune responses. J Clin Invest 1992;90:1077-84.
169. Schutzer SE, Coyle PK, Dunn JJ, Luft BJ, Brunner M. Early and specific antibody response to OspA in Lyme disease. J Clin Invest 1994;94:454-7. (Pubitemid 24218126)
170. Crother TR, Champion CI, Whitelegge JP, Aguilera R, Wu XY, Blanco DR, et al. Temporal analysis of the antigenic composition of Borrelia burgdorferi during infection in rabbit skin. Infect Immun 2004;72:5063-72. (Pubitemid 39223390)
171. Xu Q, Seemanapalli SV, McShan K, Liang FT. Constitutive expression of outer surface protein C diminishes the ability of Borrelia burgdorferi to evade specific humoral immunity. Infect Immun 2006;74:5177-84. (Pubitemid 44300436)
172. Zhang JR, Norris SJ. Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi. Infect Immun 1998;66:3689-97. (Pubitemid 28347825)
173. McDowell JV, Sung SY, Hu LT, Marconi RT. Evidence that the variable regions of the central domain of VlsE are antigenic during infection with lyme disease spirochetes. Infect Immun 2002;70:4196-203. (Pubitemid 34790928)
174. Eisendle K, Zelger B. The expanding spectrum of cutaneous borreliosis. G Ital Dermatol Venereol 2009;144:157-71.
175. Coyle PK, Schutzer SE. Neurologic aspects of Lyme disease. Med Clin North Am 2002;86:261-84. (Pubitemid 34327086)
176. Singh AE, Romanowski B. Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features. Clin Microbiol Rev 1999;12:187-209. (Pubitemid 29196850)
177. Nadelman RB, Nowakowski J, Forseter G, Goldberg NS, Bittker S, Cooper D, et al. The clinical spectrum of early Lyme borreliosis in patients with culture-confirmed erythema migrans. Am J Med 1996;100:502-8.
178. Balmelli T, Piffaretti JC. Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato. Res Microbiol 1995;146:329-40.
179. van Dam AP, Kuiper H, Vos K, Widjojokusumo A, de Jongh BM, Spanjaard L, et al. Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis. Clin Infect Dis 1993;17:708-17. (Pubitemid 23293384)
180. Schutzer SE, Janniger CK, Schwartz RA. Lyme disease during pregnancy. Cutis 1991;47:267-8.
181. Kansky A, Balic-Winter A, Bolanca-Bumber S, Skerlev M. Incidence of skin manifestations of Lyme disease in Croatia [in Croatian]. Lijec Vjesn 1992;114:25-7.
182. Strle F, Nadelman RB, Cimperman J, Nowakowski J, Picken RN, Schwartz I, et al. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia. Ann Intern Med 1999;130:32-6. (Pubitemid 29019446)
183. Flisiak I, Chodynicka B, Laudanska H, Reduta T, Stefanska-Sulik E, Pucilo K, et al. Study on clinical picture of erythema migrans. Rocz Akad Med Bialymst 1996;41:78-82.
184. Logar M, Ruzic-Sabljic E, Maraspin V, Lotric-Furlan S, Cimperman J, Jurca T, et al. Comparison of erythema migrans caused by Borrelia afzelii and Borrelia garinii. Infection 2004;32:15-9. (Pubitemid 38210507)
185. Carlsson SA, Granlund H, Jansson C, Nyman D, Wahlberg P. Characteristics of erythema migrans in Borrelia afzelii and Borrelia garinii infections. Scand J Infect Dis 2003;35:31-3. (Pubitemid 36336364)
186. Steere AC, Bartenhagen NH, Craft JE, Hutchinson GJ, Newman JH, Rahn DW, et al. The early clinical manifestations of Lyme disease. Ann Intern Med 1983;99:76-82. (Pubitemid 13066663)
187. Steere AC, Schoen RT, Taylor E. The clinical evolution of Lyme arthritis. Ann Intern Med 1987;107:725-31. (Pubitemid 18041872)
188. Kaiser R. Neuroborreliosis. J Neurol 1998;245:247-55.
189. Pinto DS. Cardiac manifestations of Lyme disease. Med Clin North Am 2002;86:285-96. (Pubitemid 34327087)
190. Wormser GP, McKenna D, Carlin J, Nadelman RB, Cavaliere LF, Holmgren D, et al. Brief communication: hematogenous dissemination in early Lyme disease. Ann Intern Med 2005;142:751-5. (Pubitemid 40593777)
191. Hovmark A, Asbrink E, Olsson I. The spirochetal etiology of lymphadenosis benigna cutis solitaria. Acta Derm Venereol 1986;66:479-84. (Pubitemid 17193386)
192. Hercogová J, Fadrhoncová A, Jirous J. Cutaneous forms of Lyme borreliosis in children [in Czech]. Cesk Pediatr 1990;45:203-8.
193. Strle F, Pleterski-Rigler D, Stanek G, Pejovnik-Pustinek A, Ruzic E, Cimperman J. Solitary borrelial lymphocytoma: report of 36 cases. Infection 1992;20:201-6.
194. Chodynicka B, Flisiak I, Okrasinska K, Andrzejewska A, Schwartz RA. Lymphocytoma cutis: cases linked with Lyme disease. Cutis 2000;66:243-6.
195. Müllegger RR. Clinical aspects and diagnosis of erythema migrans and borrelial lymphocytoma. Acta Derm Venereol (Ljubljana) 2001;10:152-8. (Pubitemid 34205278)
196. Maraspin V, Cimperman J, Lotric-Furlan S, Ruzic-Sabljic E, Jurca T, Picken RN, et al. Solitary borrelial lymphocytoma in adult patients. Wien Klin Wochenschr 2002;114:515-23. (Pubitemid 34847335)
197. Pohl-Koppe A, Wilske B, Weiss M, Schmidt H. Borrelia lymphocytoma in childhood. Pediatr Infect Dis J 1998;17:423-6. (Pubitemid 28232870)
198. Grange F, Wechsler J, Guillaume JC, Tortel J, Tortel MC, Audhuy B, et al. Borrelia burgdorferieassociated lymphocytoma cutis simulating a primary cutaneous large B-cell lymphoma. J Am Acad Dermatol 2002;47:530-4.
199. Chodynicka B, Schwartz RA, Flisiak I. Acrodermatitis chronica atrophicans. Available at: http://emedicine.medscape.com/article/1051695- overview. Accessed June 20, 2009.
200. Oldak E, Flisiak I, Chodynicka B. Lyme disease in children. Przegl Dermatol 2009;96:146-51.
201. Flisiak I, Schwartz RA, Chodynicka B. Clinical features and specific immunological response to Borrelia afzelii in patients with acrodermatitis chronica atrophicans. J Med 1999;30:267-78. (Pubitemid 30142994)
202. Asbrink E. Erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans. Early and late manifestations of Ixodes ricinuseborne Borrelia spirochetes. Acta Derm Venereol Suppl (Stockh) 1985;118:1-63.
203. Garbe C, Stein H, Gollnick H, Taud W, Orfanos CE. Cutaneous B cell lymphoma in chronic Borrelia burgdorferi infection. Report of 2 cases and a review of the literature [in German]. Hautarzt 1988;39:717-26.
204. Garbe C, Stein H, Dienemann D, Orfanos CE. Borrelia burgdorferieassociated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases. J Am Acad Dermatol 1991;24:584-90.
205. Goodlad JR, Davidson MM, Hollowood K, Ling C, MacKenzie C, Christie I, et al. Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland. Am J Surg Pathol 2000;24:1279-85.
206. Goodlad JR, Davidson MM, Hollowood K, Batstone P, Ho-Yen DO. Borrelia burgdorferieassociated cutaneous marginal zone lymphoma: a clinicopathological study of two cases illustrating the temporal progression of B burgdorferie-associated B-cell proliferation in the skin. Histopathology 2000;37:501-8. (Pubitemid 32099161)
207. Monari P, Farisoglio C, Calzavara Pinton PG. Borrelia burgdorferie-associated primary cutaneous marginal-zone B-cell lymphoma: a case report. Dermatology 2007;215:229-32. (Pubitemid 47378990)
208. Hercogová J. Borrelia burgdorferi: a protagonist in Lyme disease, a bystander in morphoea? J Eur Acad Dermatol Venereol 2002;16:98-9.
209. Aberer E, Neumann R, Stanek G. Is localised scleroderma a Borrelia infection? Lancet 1985;2:278.
210. Weide B, Walz T, Garbe C. Is morphoea caused by Borrelia burgdorferi? A review. Br J Dermatol 2000;142:636-44. (Pubitemid 30226376)
211. Wienecke R, Schlupen EM, Zochling N, Neubert U, Meurer M, Volkenandt M. No evidence for Borrelia burgdorferiespecific DNA in lesions of localized scleroderma. J Invest Dermatol 1995;104:23-6.
212. Dillon WI, Saed GM, Fivenson DP. Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America. J Am Acad Dermatol 1995;33:617-20.
213. Goodlad JR, Davidson MM, Gordon P, Billington R, Ho-Yen DO. Morphoea and Borrelia burgdorferi: results from the Scottish Highlands in the context of the world literature. Mol Pathol 2002;55:374-8. (Pubitemid 35454513)
214. Schempp C, Bocklage H, Lange R, Kolmel HW, Orfanos CE, Gollnick H. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol 1993;100:717-20. (Pubitemid 23128372)
215. Fujiwara H, Fujiwara K, Hashimoto K, Mehregan AH, Schaumburg-Lever G, Lange R, et al. Detection of Borrelia burgdorferi DNA (B garinii or B afzelii) in morphea and lichen sclerosus et atrophicus tissues of German and Japanese but not of US patients. Arch Dermatol 1997;133:41-4. (Pubitemid 27044304)
216. Breier F, Khanakah G, Stanek G, Kunz G, Aberer E, Schmidt B, et al. Isolation and polymerase chain reaction typing of Borrelia afzelii from a skin lesion in a seronegative patient with generalized ulcerating bullous lichen sclerosus et atrophicus. Br J Dermatol 2001;144:387-92. (Pubitemid 32178827)
217. Prinz JC, Kutasi Z, Weisenseel P, Poto L, Battyani Z, Ruzicka T. "Borrelia-associated early-onset morphea": a particular type of scleroderma in childhood and adolescence with high titer antinuclear antibodies? Results of a cohort analysis and presentation of three cases. J Am Acad Dermatol 2009;60:248-55.
218. Rupprecht TA, Koedel U, Fingerle V, Pfister HW. The pathogenesis of lyme neuroborreliosis: from infection to inflammation. Mol Med 2008;14:205-12. (Pubitemid 351481851)
219. Luft BJ, Steinman CR, Neimark HC, Muralidhar B, Rush T, Finkel MF, et al. Invasion of the central nervous system by Borrelia burgdorferi in acute disseminated infection. JAMA 1992;267:1364-7.
220. Rupprecht TA, Kirschning CJ, Popp B, Kastenbauer S, Fingerle V, Pfister HW, et al. Borrelia garinii induces CXCL13 production in human monocytes through Toll-like receptor 2. Infect Immun 2007;75:4351-6. (Pubitemid 47378092)
221. Schutzer SE, Coyle PK, Krupp LB, Deng Z, Belman AL, Dattwyler R, et al. Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease. J Clin Invest 1997;100:763-7. (Pubitemid 27371692)
222. Kursawe HK. Diagnosis and therapy of neuroborreliosis. On the hunt for the "great imitator" [in German]. MMW Fortschr Med 2002;144:33-6.
223. Pachner AR, Steere AC. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis. Neurology 1985;35:47-53. (Pubitemid 15193619)
224. Peltomaa M, Pyykkö I, Seppälä I, Viljanen M. Lyme borreliosis and facial paralysis-a prospective analysis of risk factors and outcome. Am J Otolaryngol 2002;23:125-32. (Pubitemid 34538634)
225. Ljostad U, Okstad S, Topstad T, Mygland A, Monstad P. Acute peripheral facial palsy in adults. J Neurol 2005;252:672-6. (Pubitemid 40864041)
226. Ishizaki H, Pyykko I, Nozue M. Neuroborreliosis in the etiology of vestibular neuronitis. Acta Otolaryngol Suppl 1993;503:67-9. (Pubitemid 23083522)
227. Peltomaa M, Pyykko I, Seppala I, Viljanen M. Lyme borreliosis - an unusual cause of vertigo. Auris Nasus Larynx 1998;25:233-42. (Pubitemid 28440582)
228. Peltomaa M, Pyykko I, Sappala I, Viitanen L, Viljanen M. Lyme borreliosis, an etiological factor in sensorineural hearing loss? Eur Arch Otorhinolaryngol 2000;257:317-22.
229. Karma A, Seppala I, Mikkila H, Kaakkola S, Viljanen M, Tarkkanen A. Diagnosis and clinical characteristics of ocular Lyme borreliosis. Am J Ophthalmol 1995;119:127-35.
230. Rothermel H, Hedges TR III, Steere AC. Optic neuropathy in children with Lyme disease. Pediatrics 2001;108:477-81.
231. Pachner AR. Defining the spectrum of Lyme disease: a difficult proposition. J Neuroophthalmol 2005;25:67-8. (Pubitemid 40791645)
232. Martzolff L, Bouhala M, Dukic R, Saraceni O, Wilhelm JM, Bombaron P, et al. Recurrent nerve palsy due to Lyme disease: report of two cases [in French]. Rev Med Interne 2010;31:229-31.
233. Berglund J, Stjernberg L, Ornstein K, Tykesson-Joelsson K, Walter H. 5-y follow-up study of patients with neuroborreliosis. Scand J Infect Dis 2002;34:421-5. (Pubitemid 34823436)
234. Kindstrand E, Nilsson BY, Hovmark A, Pirskanen R, Asbrink E. Peripheral neuropathy in acrodermatitis chronica atrophicans - a late Borrelia manifestation. Acta Neurol Scand 1997;95:338-45. (Pubitemid 27287932)
235. Zhang Y, Lafontant G, Bonner FJ Jr. Lyme neuroborreliosis mimics stroke: a case report. Arch Phys Med Rehabil 2000;81:519-21. (Pubitemid 30192049)
236. Olivares JP, Pallas F, Ceccaldi M, Viton JM, Raoult D, Planche D, et al. Lyme disease presenting as isolated acute urinary retention caused by transverse myelitis: an electrophysiological and urodynamical study. Arch Phys Med Rehabil 1995;76:1171-2.
237. Steere AC, Malawista SE, Hardin JA, Ruddy S, Askenase W, Andiman WA. Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med 1977;86:685-98.
238. Grygorczuk S, Zajkowska J, Kondrusik M, Moniuszko A, Pancewicz S, Pawlak-Zalewska W. Failures of antibiotic treatment in Lyme arthritis [in Polish]. Przegl Epidemiol 2008;62:581-8.
239. Steere AC, Gross D, Meyer AL, Huber BT. Autoimmune mechanisms in antibiotic treatment-resistant lyme arthritis. J Autoimmun 2001;16:263-8. (Pubitemid 32567513)
240. Steere AC, Dwyer E, Winchester R. Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N Engl J Med 1990;323:219-23. (Pubitemid 20225041)
241. Chodynicka B, Flisiak I, Lukaszuk C, Bulhak V. Late consequences of untreated lyme borreliosis [in Polish]. Przegl Epidemiol 1997;51:445-9.
242. Weinstein A, Britchkov M. Lyme arthritis and post-Lyme disease syndrome. Curr Opin Rheumatol 2002;14:383-7. (Pubitemid 34693981)
243. Scarti L, Baldoni D, Morelli C, Francini V, Bisogni B, Cecchi L. Acute reversible degenerative myopathy complicating Lyme disease: description of a case [in Italian]. Infez Med 1998;6:96-8. (Pubitemid 28337873)
244. Nagi KS, Joshi R, Thakur RK. Cardiac manifestations of Lyme disease: a review. Can J Cardiol 1996;12:503-6. (Pubitemid 26172461)
245. Lo R, Menzies DJ, Archer H, Cohen TJ. Complete heart block due to lyme carditis. J Invasive Cardiol 2003;15:367-9. (Pubitemid 36687687)
246. Bartunek P, Gorican K, Mrazek V, Varejka P, Veiser T, Hercogova J, et al. Lyme borreliosis infection as a cause of dilated cardiomyopathy. Prague Med Rep 2006;107:213-26.
247. Raveche ES, Schutzer SE, Fernandes H, Bateman H, McCarthy BA, Nickell SP, et al. Evidence of Borrelia autoimmunity-induced component of Lyme carditis and arthritis. J Clin Microbiol 2005;43:850-6. (Pubitemid 40256045)
248. Krause PJ, McKay K, Thompson CA, Sikand VK, Lentz R, Lepore T, et al. Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease. Clin Infect Dis 2002;34:1184-91.
249. Elston DM. What's eating you? Ixodes ticks. Cutis 2002;69:431-2. (Pubitemid 41766289)
250. Swanson SJ, Neitzel D, Reed KD, Belongia EA. Coinfections acquired from ixodes ticks. Clin Microbiol Rev 2006;19:708-27. (Pubitemid 44582978)
251. Schauber EM, Gertz SJ, Maple WT, Ostfeld RS. Coinfection of blacklegged ticks (Acari: Ixodidae) in Dutchess County, New York, with the agents of Lyme disease and human granulocytic ehrlichiosis. J Med Entomol 1998;35:901-3. (Pubitemid 128463464)
252. Benach JL, Coleman JL, Habicht GS, MacDonald A, Grunwaldt E, Giron JA. Serological evidence for simultaneous occurrences of Lyme disease and babesiosis. J Infect Dis 1985;152:473-7. (Pubitemid 15018677)
253. Aguero-Rosenfeld ME, Donnarumma L, Zentmaier L, Jacob J, Frey M, Noto R, et al. Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. J Clin Microbiol 2002;40:2612-5. (Pubitemid 34752170)
254. Brouqui P, Dumler JS, Lienhard R, Brossard M, Raoult D. Human granulocytic ehrlichiosis in Europe. Lancet 1995;346:782-3.
255. Walsh CA, Mayer EW, Baxi LV. Lyme disease in pregnancy: case report and review of the literature. Obstet Gynecol Surv 2007;62:41-50. (Pubitemid 46360533)
256. Schlesinger PA, Duray PH, Burke BA, Steere AC, Stillman MT. Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi. Ann Intern Med 1985;103:67-8. (Pubitemid 15068504)
257. MacDonald AB, Benach JL, Burgdorfer W. Stillbirth following maternal Lyme disease. N Y State J Med 1987;87:615-6. (Pubitemid 18011743)
258. Weber K, Bratzke HJ, Neubert U, Wilske B, Duray PH. Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy. Pediatr Infect Dis J 1988;7:286-9.
259. Hercogová J, Tomanková M, Frösslová D, Janovská D. Earlystage lyme borreliosis during pregnancy: treatment in 15 women with erythema migrans [in Czech]. Cesk Gynekol 1993;58:229-32. (Pubitemid 23328806)
260. Strobino BA, Williams CL, Abid S, Chalson R, Spierling P. Lyme disease and pregnancy outcome: a prospective study of two thousand prenatal patients. Am J Obstet Gynecol 1993;169:367-74. (Pubitemid 23262894)
261. Williams CL, Strobino B, Weinstein A, Spierling P, Medici F. Maternal Lyme disease and congenital malformations: a cord blood serosurvey in endemic and control areas. Paediatr Perinat Epidemiol 1995;9:320-30.
262. Maraspin V, Lotric-Furlan S, Cimperman J, Ruzic-Sabljic E, Strle F. Erythema migrans in the immunocompromised host. Wien Klin Wochenschr 1999;111:923-32. (Pubitemid 30026409)
263. Maraspin V, Cimperman J, Lotric-Furlan S, Logar M, Ruzic-Sabljic E, Strle F. Erythema migrans in solid-organ transplant recipients. Clin Infect Dis 2006;42:1751-4. (Pubitemid 43839442)
264. Furst B, Glatz M, Kerl H, Müllegger RR. The impact of immunosuppression on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients. Clin Exp Dermatol 2006;31:509-14.